|4Feb 19, 4:31 PM ET

GOLDBERG MORTON 4

4 · EYEGATE PHARMACEUTICALS INC · Filed Feb 19, 2020

Insider Transaction Report

Form 4
Period: 2020-02-14
Transactions
  • Award

    Stock Option (right to buy)

    2020-02-14+3,3333,333 total
    Exercise: $6.55Exp: 2030-02-14Common Stock (3,333 underlying)
Footnotes (1)
  • [F1]The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Plan. The Option will become fully exercisable on February 1, 2021.

Documents

1 file
  • 4
    tm209305-4_4.xmlPrimary

    OWNERSHIP DOCUMENT